2010 (840)
2011 (629)
2012 (247)
2013 (653)
2014 (1463)
2015 (155)
2016 (265)
2017 (251)
An interesting and short paper from the Journal of Current Pharmaceutical Research about how both generic names and brand names are regulated. Drugs are not allowed to start with "x" or "z" due to the risk of confusion, for example.
On branding: "The names often make use of linguistic tricks, such as
plosive letters (P, T or D) to convey power, or fricative letters (X,
F, S or Z) to imply speed. This, in part, helps explain the number of
Xs that show up in drug names. The marketing industry has been
infatuated to letter X e.g. Nexium, Clarinex, .... These letters are popular
because they look better in print, make sounds people like saying
and are associated with innovation. Moreover this flamboyant and
swashbuckling letter X is associated with science fiction, high tech,
computers, and automobiles. As per James L. Dettore the letters X, Z, C and D are phonologic and these
subliminally indicate that a drug is powerful. Few brand names
even denote the gender of the brand. Most words ending with the
'a' sound suggest feminine gender."